Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue

British Journal of Cancer

Volumn 91, Issue 3, 2004, Pages 564-571

  Hildenbrand, R ^a   Arens, N ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

DCIS; Myoepithelial cells; PAI 1; uPAR

Indexed keywords

ANTIGEN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE RECEPTOR; VITRONECTIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; BREAST DUCT; CARCINOMA IN SITU; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAMMARY GLAND; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR CELL;

ADULT; AGED; ANTIGENS, CD; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; ENZYME PRECURSORS; FEMALE; HUMANS; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 4143126864     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601990     Document Type: Article

References (24)

1. Casey JR, Petranka JG, Kottra J, Fleenor DE, Rosse WF (1994) The structure of the urokinase-type plasminogen activator receptor-gene. Blood 84: 1151-1156
2. Deng G, Curriden SA, Wang S, Rosenberg S, Loskutoff DJ (1996) Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol 134: 1563-1571
3. Falk RJ, Podack E, Dalmasso AP, Jennette JC (1987) Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol 127: 182-190
4. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA, Raffeld M (1999) Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am J Pathol 154: 61-66
5. Gebb C, Haymann EG, Engvall E, Ruoslahti E (1986) Interaction with vitronectin and collagen. J Biol Chem 261: 16698-16703
6. Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo RV, Gelehrter TD (1986) cDNA cloning of human plasminogen activator - inhibitor from endothelial cells. J Clin Invest 78: 1673-1680
7. Hildenbrand R, Glienke W, Magdolen V, Graeff H, Stutte HJ, Schmitt M (1998) Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry. Histochem Cell Biol 110: 27-32
8. Hildenbrand R, Leitz M, Magdolen V, Luther T, Albrecht S, Graeff H, Stutte HJ, Bleyl U, Schmitt M (2000) Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization. Histopathology 36: 499-504
9. Jänicke F, Schmitt M, Hafter R, Hollrieder A, Babic R, Ulm K, Gössner W, Graeff H (1990) Urokinase-type plasminogen activator (uPA) antigen is a predictor of early relapse in breast cancer. Fibrinology 4: 69-78
10. Lakhani SR, O'Hare MJ (2001) The mammary myoepithelial cell - Cinderella or ugly sister? Breast Cancer Res 3: 1-4
11. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1: 445-457
12. Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Müller M, Schmitt M (1997) Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of human urokinase receptor in tumor tissue. Am J Pathol 150: 1231-1244
13. Magdolen V, Rettenberger P, Lopens A, Oi H, Lottspeich F, Kellermann J, Creutzburg S, Goretzki L, Weidle U, Wilhelm O, Schmitt M, Graeff H (1995) Expression of the human uPA receptor (uPA-R) in E. coli and CHO cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken. Electrophoresis 16: 813-816
14. Nguyen DHD, Catling AD, Webb DJ, Snakovic M, Walker LA, Somlyo AV, Weber MJ, Gonias SL (1999) Myosin light chain kinase funtions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an intergrin-selective manner. J Cell Biol 146: 149-164
15. Page D, Dupont W, Rogers L, Landenberger M (1982) Intraductal carcinoma of the breast: follow up after biopsy only. Cancer 49: 751-758
16. Sawa H, Sobel BE, Fuji S (1993) Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type-1 by endothelial injury. Circ Res 73: 671-680
17. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höfler H, Jänicke F, Graeff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78: 285-296
18. Silverstein MJ (1998) Ductal carcinoma in situ of the breast. BMJ 317: 734-739
19. Silverstein MJ, Poller DN, Waisman JR (1995) Prognostic classification of breast ductal carcinoma in situ. Lancet 245: 1154-1157
20. Sternlicht MD, Barsky SH (1997) The myoepithelial defense: a host defense against cancer. Med Hypotheses 48: 37-46
21. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH (1997) The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3: 1949-1958
22. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA (1996) Regulation of integrin function by the urokinase receptor. Science 273: 1551-1555
23. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA (1994) Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269: 32380-32388
24. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA (1999) A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144: 1285-1294